Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
Go back to Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders| (AMEX: MBCOF) | Delayed: 0.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.11 | 52 Week High | $ | |||
| Open | $0.11 | 52 Week Low | $ | |||
| Day High | $0.11 | P/E | N/A | |||
| Day Low | $0.10 | EPS | $ | |||
| Volume | 41,000 | |||||
| Marvell Technology Group Ltd (NASDAQ: MRVL) | Delayed: 207.96 +13.02 (6.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $194.94 | 52 Week High | $13.61 | |||
| Open | $205.55 | 52 Week Low | $7.40 | |||
| Day High | $210.60 | P/E | 324.94 | |||
| Day Low | $202.84 | EPS | $0.64 | |||
| Volume | 22,129,102 | |||||
